Endymed Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 0.445 million compared to USD 0.22 million a year ago. Basic loss per share from continuing operations was USD 0.032 compared to USD 0.016 a year ago. Diluted loss per share from continuing operations was USD 0.032 compared to USD 0.016 a year ago.
For the nine months, net income was USD 0.333 million compared to USD 0.41 million a year ago. Basic earnings per share from continuing operations was USD 0.024 compared to USD 0.03 a year ago. Diluted earnings per share from continuing operations was USD 0.024 compared to USD 0.029 a year ago.